Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Meal Bolus Overestimation in Dual-Hormone Closed-Loop for T1D
NCT02626936Phase 2Completed
- Sponsor
- Montreal Clinical Research Institute
- Start
- Jan 2016
- Primary completion
- Jun 2016
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of glucagon in type 1 diabetes mellitus (T1D), sponsored by Montreal Clinical Research Institute. Started Jan 2016; status: completed.
02
Drugs
glucagon
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02626936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02626936.